December 16, 2011
Pfizer Inc. on Thursday moved to protect its kidney cancer drug Torisel, filing a pair of lawsuits against Sandoz Inc. and Accord Healthcare Ltd. in response to the companies' petitions for regulatory approval of their generic versions of the drug.